Leaflet: information for the user
Oxymetazoline Tecnimede 0.5 mg/ml nasal spray solution
Oxymetazoline hydrochloride
Read the entire leaflet carefully before starting to use this medicine, as it contains important information for you.
Follow the administration instructions for the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the leaflet
This medicine belongs to the group of medicines called sympathomimetics. It is a nasal decongestant that contains oxymetazoline as the active ingredient. Oxymetazoline, when administered nasally, produces local vasoconstriction, decongesting the nasal mucosa.
It is indicated for the local and temporary relief of nasal congestion in adults and children from 6 years of age.
You should consult a doctor if your symptoms worsen or do not improve after 3 days of treatment.
Do not use Oxymetazoline Tecnimede
Warnings and precautions
Consult your doctor or pharmacist before starting to use Oxymetazoline Tecnimede if:
In rare cases, oxymetazoline may increase nasal congestion instead of reducing it due to its temporary effects and prolonged use; this is known as rebound effect.
Insomnia may rarely occur after using the medicine. If this happens, avoid using it in the late afternoon or evening.
Do not exceed the recommended dose in section 3. How to use Oxymetazoline Tecnimede.
To avoid contagion, the medicine should not be used by more than one person, and the applicator should be cleaned after each use with a clean, damp cloth.
Children
Do not use in children under 6 years of age.
Children may be especially prone to adverse effects of this medicine.
Using Oxymetazoline Tecnimede with other medicines
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.
This medicine should not be used by people who are taking or have taken during the last two weeks: medications used to treat depression (tricyclic antidepressants or monoamine oxidase inhibitors (MAOIs)) or with a medication to lower blood pressure called methyldopa.
It should also not be used in case of treatment with phenothiazine (a tranquilizer) or with medications to treat asthma.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
This medicine should not be used during pregnancy or breastfeeding.
Although problems are not expected, if you experience drowsiness or dizziness, do not drive or use hazardous tools or machines.
Follow the administration instructions for the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The recommended dose is:
Adults and children from 6 years of age: 1 spray in each nostril, no more than 2 times in 24 hours. If necessary, a second spray can be administered in each nostril in each application, in the case of adults.
Use in children
This medicine should not be used in children under 6 years of age.
How to use
This medicine is used nasally.
Before applying this medicine, existing nasal fluids should be eliminated by blowing your nose well.
To avoid contagion, after each use and before closing the package, the applicator tip should be cleaned with a clean, damp cloth. Additionally, each package should be used by only 1 person.
If it is the first time using this product or it has not been used for a long time, the sprayer needs to be loaded. To do this, holding the package away from the body, press the sprayer several times until a finally pulverized liquid comes out.
For the application of the spray, the head should be held upright.
1- Remove the protective cap from the bottle | 2- Hold the bottle by placing the index and middle fingers on the top and the thumb under the bottle | 3- Direct the bottle towards the nose and press downwards while inhaling deeply, pressing the sprayer and keeping the head up |
If your symptoms worsen or do not improve after 3 days of treatment, discontinue treatment and consult your doctor.
Elderly patients
Consult your doctor or pharmacist, as older people are more sensitive to the adverse effects of this medicine.
If you use more Oxymetazoline Tecnimede than you should
Due to excessive or continuous dosing, you may experience: headache, tremors, insomnia, excessive sweating, palpitations, tachycardia, increased blood pressure, or sleep disturbances.
In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicology Information Service (phone: 91.5620420), indicating the medicine and the amount ingested.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
During the use of oxymetazoline, the following side effects have been observed, whose frequency could not be established with precision.
The most common side effects are:
Irritation at the application site, dryness, itching of the nasal mucosa, or sneezing.
Rare side effects that may occur are:
Anxiety, restlessness, insomnia, hallucinations, tremors, and sleep disorders in children.
Tachycardia, palpitations, increased blood pressure.
Headache, nausea, skin rash (redness of the skin).
Excessive or prolonged use may lead to nasal congestion.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the package, after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of through wastewater or household waste. Deposit the packages and medicines you no longer need at the SIGRE point in your pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medicines you no longer need. This will help protect the environment.
Composition of Oxymetazoline Tecnimede
The active ingredient is: oxymetazoline hydrochloride. Each ml contains 0.5 mg of oxymetazoline hydrochloride (35 micrograms per 0.07 spray).
The other components (excipients) are: benzalkonium chloride 0.2 mg/ml, potassium dihydrogen phosphate, anhydrous disodium hydrogen phosphate, purified water.
Appearance of the product and package contents
It is presented as a clear, colorless solution in a package with a dosing pump for nasal application.
The package is white and contains 15 ml of solution for nasal spray.
Marketing authorization holder and manufacturer:
Marketing authorization holder
Tecnimede España Industria Farmacéutica, S.A.
Avda. de Bruselas, 13, 3º D.
28108 Alcobendas (Madrid)
Spain
Manufacturer
Laboratorios Alcalá Farma, S.L.
Avenida de Madrid, 82
28802 Alcalá de Henares, Madrid - Spain
Date of the last revision of this leaflet:April 2017
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/.